Lu-Wen Wang
Impact in
- Hepatology top 5%
- Liver Disease and Transplantation
- Hepatitis C virus research
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Histone Deacetylase Inhibitors Research 6
- Epigenetics and DNA Methylation 4
- Epidemiology 13
- Liver Disease Diagnosis and Treatment 10
- Hepatitis B Virus Studies 4
- Co-authors
- Zuojiong Gong (32 shared papers)Fan Yang (11 shared papers)Fangzhou Jiao (10 shared papers)Yao Wang (10 shared papers)Haiyue Zhang (8 shared papers)Wenbin Zhang (7 shared papers)Xun Li (6 shared papers)Hong Zhang (2 shared papers)
- Journals
- International Journal of Molecular Sciences (3 papers)World Journal of Gastroenterology (3 papers)Scientific Reports (2 papers)Biomedicine & Pharmacotherapy (2 papers)Life Sciences (2 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Lu-Wen Wang
45 papers receiving 901 citations
Peers
Comparison fields: 5 of 106
- Hepatology 156
- Pharmacology 142
- Clinical Biochemistry 78
- Epidemiology 267
- Cancer Research 102
Countries citing papers authored by Lu-Wen Wang
This map shows the geographic impact of Lu-Wen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu-Wen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu-Wen Wang more than expected).
Fields of papers citing papers by Lu-Wen Wang
This network shows the impact of papers produced by Lu-Wen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu-Wen Wang. The network helps show where Lu-Wen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu-Wen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 89 | |
| 2 | 2019 | 80 | |
| 3 | 2018 | 59 | |
| 4 | 2014 | 44 | |
| 5 | 2010 | 39 | |
| 6 | 2020 | 37 | |
| 7 | 2017 | 37 | |
| 8 | 2020 | 35 | |
| 9 | 2013 | 34 | |
| 10 | 2018 | 28 | |
| 11 | 2013 | 28 | |
| 12 | 2012 | 27 | |
| 13 | High mobility group box-1 protein inhibits regulatory T cell immune activity in liver failure in patients with chronic hepatitis B. | 2010 | 27 |
| 14 | 2014 | 25 | |
| 15 | 2019 | 24 | |
| 16 | 2019 | 21 | |
| 17 | 2015 | 21 | |
| 18 | 2010 | 20 | |
| 19 | Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells. | 2004 | 20 |
| 20 | 2023 | 17 |
About Lu-Wen Wang
Lu-Wen Wang is a scholar working on Molecular Biology, Epidemiology, Hepatology, Clinical Biochemistry and Physiology, having authored 48 papers that have together received 916 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), Advanced Glycation End Products research (7 papers), Histone Deacetylase Inhibitors Research (6 papers), Hepatitis B Virus Studies (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Epigenetics and DNA Methylation (4 papers), Hepatitis C virus research (4 papers) and Biochemical Acid Research Studies (4 papers). The work is most often cited by research in Hepatology (156 citations), Pharmacology (142 citations), Clinical Biochemistry (78 citations), Epidemiology (267 citations) and Cancer Research (102 citations). Lu-Wen Wang has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Zuojiong Gong, Fan Yang, Fangzhou Jiao, Yao Wang, Haiyue Zhang, Wenbin Zhang, Xun Li, Hong Zhang, Likun Wang and Xun Li. Their work appears in journals such as International Journal of Molecular Sciences, World Journal of Gastroenterology, Scientific Reports, Biomedicine & Pharmacotherapy and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.